Alexandra Toohey
@Baker Bros. Advisors Lp
Latest period2024 - Q3ReportedManaged Assets$9.649BTotal holdings93
Assets growth rate23.31%Assets growth rate (2-Q avg)10.74%Continuous growth in asset value1 quarters
Portfolio positions
This chart displays the top 10 holdings in Baker Bros. Advisors Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 93 positions.
Assets under management
The assets under management (AUM) of Baker Bros. Advisors Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 9.649B in assets, with a quarterly growth rate of 23.31% and a 2-quarter average growth rate of 10.74%. The portfolio is managed by Alexandra Toohey, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
BCAXBicara Therapeutics Inc.
| 0.22% | $21.225M 833,333 shares@ $25.48 avg price | New Position |
ARVNArvinas, Inc.
| 0.11% | $9.989M 405,576 shares@ $24.64 avg price | New Position |
IONSIonis Pharmaceuticals, Inc.
| 0.1% | $8.952M 223,470 shares@ $40.06 avg price | New Position |
GPCRStructure Therapeutics Inc.
| 0.04% | $3.753M 85,500 shares@ $43.89 avg price | New Position |
WVEWave Life Sciences Ltd.
| 0.03% | $2.821M 344,063 shares@ $8.21 avg price | New Position |
ALGSAligos Therapeutics, Inc.
| 0.01% | $719,256 83,055 shares@ $8.66 avg price | New Position |